Ethylene glycol

Ethylene glycol (CAS No.: 107-21-1) is a small-molecule diol widely used in biomedical research as a cryoprotective agent and synthetic intermediate, belonging to the class of low-molecular-weight polyols that modulate cellular responses to low-temperature stress. It readily permeates biological membranes and exerts its primary mechanism of action by reducing ice nucleation and growth during freezing, thereby lowering the freezing point of intracellular and extracellular solutions and minimizing mechanical damage associated with ice crystal formation. Through these physicochemical effects, it preserves membrane integrity, protein structure, and cellular viability, making it a critical component in protocols for the cryopreservation of cells, tissues, and embryos, particularly in stem cell research and mammalian reproductive biology. Ethylene glycol does not act through a specific molecular target or canonical signaling pathway but instead influences cellular survival via osmotic balance and vitrification processes; accordingly, conventional pharmacological metrics such as IC50 or EC50 are not typically applicable. In vitro and ex vivo applications commonly include its use in cryostorage media for primary cells, organoids, and reproductive materials, as well as in tissue preservation workflows, while in vivo use is generally limited to methodological development rather than therapeutic intervention. Experimental concentrations are highly context-dependent and are optimized to balance cryoprotection with cytotoxicity, which can arise at elevated levels due to osmotic stress or metabolic perturbation. Beyond cryobiology, it also serves as a precursor in polymer and nanomaterial synthesis, supporting its utility in interdisciplinary research settings spanning drug delivery and biomaterials engineering.